Article 20

1. If several applications have been submitted in accordance with Article 5 for marketing authorization for the same veterinary medicinal product and one or more Member States have granted such authorization while one or more of the other Member States have withheld it, one of the Member States concerned may bring the matter before the Committee. The same shall apply where one or more Member States have suspended or withdrawn marketing authorization while one or more of the other Member States have not done so. 2. The Committee shall consider the matter and shall deliver its reasoned opinion within 120 days at the latest. 3. The opinion of the Committee shall deal only with the grounds on which authorization was refused, suspended or withdrawn. The Committee shall forthwith inform the Member States concerned of its opinion or, in the event of dissension, of the opinions of its members. 4. The Member States concerned shall give notice, within 30 days, of the action they intend to take following the Committee's opinion.

← 3. · All articles · 1. →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.